Ensign Peak Advisors, Inc Jazz Pharmaceuticals PLC Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 26,247 shares of JAZZ stock, worth $3.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,247

Previous 28,084 6.54%

Holding current value

$3.22 Million

Previous $3 Million 2.4%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.57 - $116.37 $184,747 - $213,771	-1,837 Reduced 6.54%	26,247 $2.93 Million
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $129,405 - $148,130	-1,245 Reduced 4.24%	28,084 $3 Million
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $646,791 - $745,503	-5,615 Reduced 16.07%	29,329 $3.53 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $413,049 - $491,640	3,615 Added 11.54%	34,944 $4.3 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $906,338 - $1.08 Million	7,429 Added 31.08%	31,329 $4.06 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $458,150 - $550,378	-3,740 Reduced 13.53%	23,900 $2.96 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $205,659 - $246,321	1,535 Added 5.88%	27,640 $4.04 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $55,779 - $68,735	-430 Reduced 1.62%	26,105 $4.16 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $107,601 - $137,003	-850 Reduced 3.1%	26,535 $3.54 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $562,820 - $670,423	3,975 Added 16.98%	27,385 $4.27 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $663,756 - $822,784	-5,120 Reduced 17.95%	23,410 $3.64 Million
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $9.13 Million - $11.1 Million	-76,190 Reduced 72.76%	28,530 $3.64 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $3.65 Million - $5.24 Million	-28,375 Reduced 21.32%	104,720 $13.6 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $503,828 - $586,290	-3,145 Reduced 2.31%	133,095 $23.6 Million
Q1 2021 May 12, 2021	SELL	$150.19 - $173.5 $6.93 Million - $8.01 Million	-46,170 Reduced 25.31%	136,240 $22.4 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $12 Million - $14.1 Million	-85,340 Reduced 31.87%	182,410 $30.1 Million
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $751,929 - $1.03 Million	7,130 Added 2.74%	267,750 $38.2 Million
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $4.73 Million - $6.02 Million	-49,430 Reduced 15.94%	260,620 $28.8 Million
Q1 2020 May 11, 2020	BUY	$87.74 - $152.74 $62,295 - $108,445	710 Added 0.23%	310,050 $30.9 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $36.4 Million - $47.6 Million	309,340 New	309,340 $46.2 Million

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.69B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Jazz Pharmaceuticals PLC Transaction History